| Hardin, Dana S; Ahn, Chul; Prestidge, Claude et al. (2005) Growth hormone improves bone mineral content in children with cystic fibrosis. J Pediatr Endocrinol Metab 18:589-95 |
| Hardin, D S; Leblanc, A; Marshall, G et al. (2001) Mechanisms of insulin resistance in cystic fibrosis. Am J Physiol Endocrinol Metab 281:E1022-8 |
| Hardin, D S; Arumugam, R; Seilheimer, D K et al. (2001) Normal bone mineral density in cystic fibrosis. Arch Dis Child 84:363-8 |
| Hardin, D S; Ellis, K J; Dyson, M et al. (2001) Growth hormone decreases protein catabolism in children with cystic fibrosis. J Clin Endocrinol Metab 86:4424-8 |
| Hardin, D S; LeBlanc, A; Para, L et al. (1999) Hepatic insulin resistance and defects in substrate utilization in cystic fibrosis. Diabetes 48:1082-7 |
| Hardin, D S; LeBlanc, A; Young, D et al. (1999) Increased leucine turnover and insulin resistance in men with advanced HIV infection. J Investig Med 47:405-13 |
| Hardin, D S; LeBlanc, A; Lukenbaugh, S et al. (1998) Proteolysis associated with insulin resistance in cystic fibrosis. Pediatrics 101:433-7 |
| Arumugam, R; LeBlanc, A; Seilheimer, D K et al. (1998) Serum leptin and IGF-I levels in cystic fibrosis. Endocr Res 24:247-57 |
| Hardin, D S; LeBlanc, A; Lukenbough, S et al. (1997) Insulin resistance is associated with decreased clinical status in cystic fibrosis. J Pediatr 130:948-56 |
